Clinical Trial

Dose Optimization of MDMA-Assisted Therapy for PTSD

Study acronym: DosOp
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This open label, within-subjects dose optimization trial will investigate the optimal number of MDMA-Assisted Therapy treatment cycles (i.e., one MDMA session and three integration sessions) in a sample of U.S. veterans with PTSD. Participants will complete from one to five cycles of MDMA-AT.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-13.
Status change: Not Yet Recruiting → Recruiting 2025-06-23
Trial Details
NCT Number NCT06418178
Lead Sponsor Bronx VA Medical Center
Conditions Posttraumatic Stress Disorder
Enrollment 60 participants
Start Date 2025-06-03
Primary Completion 2029-10 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2025-06-26